Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 209

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Efficacy of desmopressin in the treatment of nocturia: a double‐blind placebo‐controlled study in men

Open access
Mattiasson, A., Abrams, P., Van Kerrebroeck, P., Walter, S., Weiss, J. · 2002 · BJU International

Abstract

Objective To investigate the efficacy and safety of oral desmopressin in the treatment of nocturia in men. Patients and methods Men aged 18 years with verified nocturia (two voids/night) and nocturnal urine production greater than their maximum functional bladder capacity were recruited. A 3‐week dose‐titration phase established the optimum desmopressin dose (0.1, 0.2 or 0.4 mg). After a 1‐week ‘washout’ period, patients who responded in the dose‐titration period were randomized to receive the optimal dose of desmopressin or placebo in a double‐blind design for 3 weeks. Results In all, 151 patients entered the double‐blind period (86 treated with desmopressin, 65 with placebo). In the desmopressin group 28 (34%) patients and in the placebo group two (3%) patients ( P <0.001) had fewer than half the number of nocturnal voids relative to baseline; the mean number of nocturnal voids decreased from 3.0 to 1.7 and from 3.2 to 2.7, respectively, reflecting a mean decrease of 43% and 12% ( P <0.001). The mean duration of the first sleep period increased by 59% (from 2.7 to 4.5 h) in the desmopressin group, compared with an increase of 21% (from 2.5 to 2.9 h) in the placebo group ( P <0.001). The mean nocturnal diuresis decreased by 36% (from 1.5 to 0.9 mL/min) in the desmopressin group and by 6% (from 1.7 to 1.5 mL/min) in the placebo group ( P <0.001). The mean ratio of night/24‐h urine volume decreased by 23% and 1% ( P <0.001), and the mean ratio of night/day urine volume decreased by 27% and increased by 3% ( P <0.001) for the desmopressin and placebo groups, respectively. In the double‐blind treatment period, similar numbers of patients had adverse events; 15 (17%) patients in the desmopressin and 16 (25%) patients in the placebo group. Most adverse events were mild. Serum sodium levels were <130 mmol/L in 10 (4%) patients and this occurred during dose‐titration. Conclusions Orally administered desmopressin is an effective and well‐tolerated treatment for nocturia in men.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-410x.2002.02791.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 209

Metadata

Authors
Mattiasson, A., Abrams, P., Van Kerrebroeck, P., Walter, S., & Weiss, J.
Venue
BJU International
Publisher
Wiley
Published
2002-05-12
Volume
89
Issue
9
Pages
855-862
ISSN
  • 1464-4096 (ISSN-L)
  • 1464-410X
OpenAlex
W2138305196
Cited by
209
References
1
FWCI
8.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of desmopressin in the treatment of nocturia: a double‐blind placebo‐controlled study in men. https://app.cochat.ai/papers/10.1046/j.1464-410x.2002.02791.x
The paper
Mattiasson, A., Abrams, P., Van Kerrebroeck, P., Walter, S., & Weiss, J. (2002). Efficacy of desmopressin in the treatment of nocturia: a double‐blind placebo‐controlled study in men. BJU International. https://doi.org/10.1046/j.1464-410x.2002.02791.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.